Bulletin of the American Physical Society
APS March Meeting 2020
Volume 65, Number 1
Monday–Friday, March 2–6, 2020; Denver, Colorado
Session W26: Interrogating Biomolecules with Synthetic Nanostructures
8:00 AM–11:00 AM,
Friday, March 6, 2020
Room: 403
Sponsoring
Units:
DBIO DSOFT DCP DFD
Chair: Binquan Luan, IBM TJ Watson Research Center
Abstract: W26.00002 : Protein-Corona-by-Design in 2D: A Molecular Dynamics study to Decode Bio-Nano Interactions for Quality-by-Design Nanomedicines*
Presenter:
Mohamed Ali Al-Badri
(Physics, King's College London)
Authors:
Mohamed Ali Al-Badri
(Physics, King's College London)
Khuloud al-Jamal
(Institute of Pharmaceutical Science, King's College London)
Christian Lorenz
(Physics, King's College London)
Collaboration:
Mohamed Ali Al-Badri
Understanding and controlling the interaction of graphene-based materials with proteins is key to the development of graphene-enabled biomedical technologies and to the successful delivery of chemotherapy drugs. Little is known about the fundamental atomistic behaviour of the interactions of proteins exposed to functional groups on 2D synthetic materials. Here we investigate the interaction of graphitic materials with an array of proteins with all-atom molecular dynamics simulations and perform analytical modelling ito identify safe and toxic protein corona profiles in 2D that could pave the way for future quality by design 2D/3D nanomedicines & better clinical translation.
*This work was supported by BBSRC (grant BB/M009513/1)
Follow Us |
Engage
Become an APS Member |
My APS
Renew Membership |
Information for |
About APSThe American Physical Society (APS) is a non-profit membership organization working to advance the knowledge of physics. |
© 2024 American Physical Society
| All rights reserved | Terms of Use
| Contact Us
Headquarters
1 Physics Ellipse, College Park, MD 20740-3844
(301) 209-3200
Editorial Office
100 Motor Pkwy, Suite 110, Hauppauge, NY 11788
(631) 591-4000
Office of Public Affairs
529 14th St NW, Suite 1050, Washington, D.C. 20045-2001
(202) 662-8700